Skip to main content
. Author manuscript; available in PMC: 2011 Jan 15.
Published in final edited form as: Cancer. 2010 Jan 15;116(2):355–361. doi: 10.1002/cncr.24769

TABLE 1.

Gynecologic Oncology Group Treatment Protocols of the Study Group

Treatment Number of Patients
GOG protocol Arm A Arm B White Black
GOG 107 Doxorubicin 60 mg/m2 Doxorubicin 60 mg/m2 and
cisplatin 50 mg/m2 		237 34
GOG 139 Doxorubicin 60 mg/m2 over 30
min and cisplatin 60 mg/m2
over 30 min		 Doxorubicin 60 mg/m2 over 30
min at 6 a.m. and cisplatin 60
mg/m2 over 30 min at 6 p.m.		 271 53
GOG 163 Doxorubicin 60 mg/m2 and
cisplatin 50 mg/m2 		Doxorubicin 60 mg/m2, 24-h
infusion paclitaxel at a dose of
150 mg/m2, and G-CSF at a
dose of 5 mcg/kg on Days 3-
12		 258 45
GOG 177 Doxorubicin 60 mg/m2 and
cisplatin 50 mg/m2 		Doxorubicin 45 mg/m2 on Day
1, cisplatin, 50 mg/m2 on Day
1, 3-h infusion paclitaxel at a
dose of 160 mg/m2, on Day 2,
and G-CSF at a dose of 5
mcg/kg on Days 3-12		 216 37